These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 12559562

  • 1. The ETO (MTG8) gene family.
    Davis JN, McGhee L, Meyers S.
    Gene; 2003 Jan 16; 303():1-10. PubMed ID: 12559562
    [Abstract] [Full Text] [Related]

  • 2. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Melnick A, Carlile GW, McConnell MJ, Polinger A, Hiebert SW, Licht JD.
    Blood; 2000 Dec 01; 96(12):3939-47. PubMed ID: 11090081
    [Abstract] [Full Text] [Related]

  • 3. Multiple regions of ETO cooperate in transcriptional repression.
    Hildebrand D, Tiefenbach J, Heinzel T, Grez M, Maurer AB.
    J Biol Chem; 2001 Mar 30; 276(13):9889-95. PubMed ID: 11150306
    [Abstract] [Full Text] [Related]

  • 4. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins.
    Barseguian K, Lutterbach B, Hiebert SW, Nickerson J, Lian JB, Stein JL, van Wijnen AJ, Stein GS.
    Proc Natl Acad Sci U S A; 2002 Nov 26; 99(24):15434-9. PubMed ID: 12427969
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.
    Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, Downing JR, Meyers S, Hiebert SW.
    Mol Cell Biol; 2001 Oct 26; 21(19):6470-83. PubMed ID: 11533236
    [Abstract] [Full Text] [Related]

  • 7. Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML.
    Guo C, Li J, Steinauer N, Wong M, Wu B, Dickson A, Kalkum M, Zhang J.
    J Biol Chem; 2020 Mar 27; 295(13):4212-4223. PubMed ID: 32071087
    [Abstract] [Full Text] [Related]

  • 8. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.
    Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM.
    Proc Natl Acad Sci U S A; 1998 Sep 01; 95(18):10860-5. PubMed ID: 9724795
    [Abstract] [Full Text] [Related]

  • 9. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein.
    Melnick AM, Westendorf JJ, Polinger A, Carlile GW, Arai S, Ball HJ, Lutterbach B, Hiebert SW, Licht JD.
    Mol Cell Biol; 2000 Mar 01; 20(6):2075-86. PubMed ID: 10688654
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors.
    Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW.
    Mol Cell Biol; 1998 Dec 01; 18(12):7176-84. PubMed ID: 9819404
    [Abstract] [Full Text] [Related]

  • 12. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells.
    Era T, Asou N, Kunisada T, Yamasaki H, Asou H, Kamada N, Nishikawa S, Yamaguchi K, Takatsuki K.
    Genes Chromosomes Cancer; 1995 May 01; 13(1):25-33. PubMed ID: 7541640
    [Abstract] [Full Text] [Related]

  • 13. Molecular basis of the t(8;21) translocation in acute myeloid leukaemia.
    Ohki M.
    Semin Cancer Biol; 1993 Dec 01; 4(6):369-75. PubMed ID: 8142622
    [Abstract] [Full Text] [Related]

  • 14. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).
    Nucifora G, Rowley JD.
    Leuk Lymphoma; 1994 Aug 01; 14(5-6):353-62. PubMed ID: 7812194
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional repression by leukaemia-associated ETO family members can be independent of oligomerization and coexpressed hSIN3B and N-CoR.
    Olsson A, Olsson I, Dhanda RS.
    Biochim Biophys Acta; 2008 Oct 01; 1779(10):590-8. PubMed ID: 18586123
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The t(8;21) translocation converts AML1 into a constitutive transcriptional repressor.
    Wildonger J, Mann RS.
    Development; 2005 May 01; 132(10):2263-72. PubMed ID: 15829516
    [Abstract] [Full Text] [Related]

  • 18. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
    Kwong YL, Chan V, Wong KF, Chan TK.
    Cancer; 1995 Feb 01; 75(3):821-5. PubMed ID: 7828132
    [Abstract] [Full Text] [Related]

  • 19. Structure of the AML1-ETO NHR3-PKA(RIIα) complex and its contribution to AML1-ETO activity.
    Corpora T, Roudaia L, Oo ZM, Chen W, Manuylova E, Cai X, Chen MJ, Cierpicki T, Speck NA, Bushweller JH.
    J Mol Biol; 2010 Sep 24; 402(3):560-77. PubMed ID: 20708017
    [Abstract] [Full Text] [Related]

  • 20. RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis.
    Yan M, Ahn EY, Hiebert SW, Zhang DE.
    Blood; 2009 Jan 22; 113(4):883-6. PubMed ID: 19036704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.